Medtech Trends 2026: What Global Shifts Mean for South Asia's Healthcare Industry

Executive Summary

The global medical technology (medtech) sector is navigating a period of structural change, driven by policy reforms, evolving care delivery models, supply chain realignment, and the rise of enabling technologies. These shifts carry significant implications for South Asia, a region with rapidly growing healthcare needs and expanding manufacturing capabilities. Drawing on Clarivate's Medtech Trends to Watch in 2026 report, this article examines five pivotal trends and their potential impact on South Asia's healthcare economy, industrial strategy, and investment prospects.

Introduction

South Asia is emerging as a key player in the global healthcare landscape. With a combined population of nearly two billion, the region faces both challenges and opportunities in delivering accessible, affordable, and advanced medical care. The medtech industry—encompassing medical devices, diagnostics, and health technology—is central to this evolution. As global market dynamics shift, South Asian countries must adapt to the changing environment to remain competitive and attract investment.

Main Analysis

1. Volume-Based Procurement and Pricing Pressures

Clarivate highlights the expansion of China's volume-based procurement (VBP) as a defining force in global medtech pricing. VBP programs have driven down device prices, altered competitive dynamics, and encouraged domestic innovation. For South Asia, the implications are twofold. On one hand, price reductions in China can influence price expectations across emerging markets, including South Asia, where cost sensitivity is high. On the other hand, the rise of Chinese manufacturers could intensify competition in the region.

South Asian governments could learn from China's approach to regulate device pricing while ensuring industry sustainability. India's existing price controls on medical devices, for instance, may need to evolve in response to these global trends. Companies operating in South Asia must reassess their market entry and pricing strategies to remain viable.

2. Shift to Outpatient and Ambulatory Care

The migration of procedures from hospitals to outpatient settings is a global trend reinforced by U.S. policy changes. In South Asia, day surgery and outpatient care are gaining traction as a way to reduce costs and expand access, especially in urban areas. This shift necessitates the development of ambulatory surgical centers (ASCs) and the adoption of minimally invasive technologies.

For medtech manufacturers, this means designing products that are suited to outpatient settings—compact, easy to use, and cost-effective. It also opens opportunities for equipment leasing and training services. South Asia's private healthcare providers are already investing in ASC models, and this trend is likely to accelerate, creating new demand for specialized devices.

3. Supply Chain Resilience and Manufacturing Diversification

Global supply chain disruptions have prompted medtech companies to reconsider their manufacturing footprints. South Asia, particularly India, is positioned to benefit from this diversification as multinationals seek alternative production bases. India's medical device manufacturing ecosystem, supported by government initiatives such as the Production Linked Incentive (PLI) scheme, is poised for growth.

However, the region must address challenges including infrastructure gaps, skilled workforce shortages, and regulatory complexities. Strengthening regional supply chains and fostering collaboration among South Asian countries could enhance resilience and create economies of scale.

4. GLP-1 Therapies and Metabolic Health

The rapid adoption of GLP-1 receptor agonists for weight management is reshaping clinical pathways and affecting medtech markets, particularly bariatric surgery. South Asia has a high and growing prevalence of obesity and diabetes, making these therapies highly relevant. As pharmaceutical interventions become more common, the demand for surgical weight-loss procedures may soften, impacting manufacturers of bariatric devices.

Yet, the broader shift toward metabolic health could spur innovation in diagnostic and monitoring technologies. South Asian companies could explore partnerships to develop integrated solutions that combine pharmacotherapy with digital health tools.

5. Enabling Technologies and Platform-Based Competition

Robotics, imaging, navigation, and digital workflows are converging to create integrated platforms that enhance surgical precision and streamline care. In South Asia, the adoption of such technologies is uneven but accelerating, particularly in tertiary care centers and private hospitals. The growth of telemedicine and AI-driven diagnostics is also opening new avenues.

To compete in this evolving landscape, South Asian firms must invest in research and development, foster innovation ecosystems, and build partnerships with global technology providers. Governments can play a role by creating regulatory sandboxes and funding research in enabling technologies.

Regional Impact

The combined impact of these trends will be profound for South Asia. Economically, the medtech sector can become a significant contributor to GDP growth and job creation. Industrial development will benefit from increased local manufacturing and technology adoption. Trade integration within the region could be enhanced through the establishment of regional standards and cross-border supply chains. Investment will likely flow into countries that offer a competitive manufacturing environment and a large consumer market.

Technology adoption can improve healthcare outcomes and foster innovation ecosystems. The shift to outpatient care can enhance efficiency and lower costs. However, without strategic action, South Asia risks being a passive recipient of global trends rather than an active shaper.

Strategic Insights

For businesses, the key is to align product portfolios with evolving clinical and economic imperatives. Multinational corporations may need to recalibrate their South Asia strategies to reflect local pricing realities and supply chain demands. Domestic companies can seize opportunities by focusing on niche products, contract manufacturing, and digital health solutions.

Investors should look at the region's medtech potential, especially in India and Bangladesh, where policy support and demand are strong. Public-private partnerships in healthcare infrastructure can be lucrative. Policymakers must prioritize regulatory harmonization, intellectual property protection, and skill development to attract investment.

International partnerships, particularly with technology leaders, can accelerate capability building. South Asia can also serve as a bridge between global markets, leveraging its cost advantages and engineering talent.

Future Outlook

Over the next three to five years, South Asia's medtech sector is likely to undergo rapid transformation. The adoption of AI and robotics in healthcare will gain momentum, with India emerging as a hub for medical device innovation. Manufacturing will expand, driven by global diversification and local demand. The region's growing middle class will fuel demand for advanced healthcare services, creating a virtuous cycle.

However, challenges remain. Fragmented regulatory frameworks, uneven infrastructure, and limited access to capital for startups could hinder progress. To realize the full potential, South Asia must foster a cohesive regional strategy that leverages shared strengths and addresses common weaknesses.

Conclusion

The medtech trends of 2026 offer both challenges and opportunities for South Asia. By understanding these global forces and responding strategically, the region can position itself as a competitive player in the global healthcare economy. The time to act is now—for businesses, investors, and governments alike.

Key Takeaways

• Global medtech pricing reforms and supply chain shifts are creating opportunities for South Asian manufacturing.
• The movement to outpatient care demands new product designs and service models.
• GLP-1 therapies are altering demand for surgical devices, requiring portfolio adjustments.
• Enabling technologies are driving a shift to platform-based competition, necessitating investment in R&D.
• South Asia's competitive advantage lies in its demographic, manufacturing capability, and digital talent.

Sources

• Clarivate, "5 medtech trends to watch in 2026" (2026). Link